Yilin Cao

Yilin Cao

Auto-generated profile, based on publicly available information

Yilin Cao

Department of Radiation Oncology and Molecular Radiation Sciences Johns Hopkins University School of Medicine Baltimore Maryland USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
YCYilin Cao
Yilin Cao
HCHanbo Chen
Hanbo Chen
ASArjun Sahgal
Arjun Sahgal
DEDarby Erler
Darby Erler
SBSerena Badellino
Serena Badellino
KRKristin J. Redmond
Kristin J. Redmond

20 October 2021 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
YCYilin Cao
Yilin Cao
HCHanbo Chen
Hanbo Chen
ASArjun Sahgal
Arjun Sahgal
DEDarby Erler
Darby Erler
SBSerena Badellino
Serena Badellino
KRKristin J. Redmond
Kristin J. Redmond
Background: We hypothesized that the total volume of metastases at initial oligometastatic (OM) presentation to stereotactic body radiation therapy (SBRT) is an important prognostic factor that can refine the definition of OM disease.Methods: Patients with extracranial oligometastatic cancer (≤5 lesions) treated with SBRT were included in an international multi‐institutional database. Multivariable Cox and competing risks regression models were used to determine the relationship between distant progression‐free survival (DPFS), widespread progression (WSP), and overall survival (OS) with the total planning target volume (PTV) at initial OM presentation to SBRT. All models were adjusted for histology, pre‐SBRT systemic therapy, osseous‐only lesions, and number of metastases.Results: In total, 961 patients were included. The median follow‐up was 24.4 months (IQR: 13.8–37.5). Total PTV had a significant effect on DPFS in the first 18 months after SBRT and was most profound in the first 6 months, when each twofold increase in total PTV conferred a 40.6% increased risk of distant progression (p < 0.001). Each twofold increase in total PTV increased the risk of WSP by 45.4% in the first 6 months (p < 0.001). Total PTV had a significant effect on OS in the first 2 years after SBRT, with each twofold PTV change increasing the risk of death by 60.7% during the first 6 months (p < 0.001) and by 34% thereafter (p < 0.001). Exploratory gross tumor volume (GTV) analysis confirmed the PTV‐based observations.Conclusion: The total volumetric burden of metastases at initial OM presentation to SBRT is strongly and independently prognostic for the risk of distant and widespread progression and survival. We propose that this metric should drive the definition of OM disease and guide treatment decision‐making.


1 October 2017 in International Journal of Radiation Oncology, Biology, Physics
Verified
Journal Article
Open access
YCY. Cao
Y. Cao
LCLi Chen
Li Chen
ANAmol Narang
Amol Narang
ZGZ.D. Guss
Z.D. Guss
JMJoseph Moore
Joseph Moore
JHJoseph M. Herman
Joseph M. Herman

11 January 2022 in The Prostate
Verified
Journal Article
Closed access
PDF file
YCYilin Cao
Yilin Cao
DSDaniel Y. Song
Daniel Y. Song
CDCurtiland Deville
Curtiland Deville
TDTheodore L. DeWeese
Theodore L. DeWeese
SGStephen Greco
Stephen Greco
MDMatthew P. Deek
Matthew P. Deek